市场调查报告书
商品编码
1433334
全球软骨修復市场2023-2030Global Cartilage Repair Market 2023-2030 |
预计全球软骨修復市场在预测期(2023-2030年)将以5.2%的CAGR成长。骨关节炎等骨关节疾病发病率的增加以及软骨再生技术的进步推动了市场的成长。骨关节炎盛行率的增加归因于老年人口的不断扩大以及肥胖和其他相关因素的影响不断加大等因素。根据世界卫生组织统计,2019年,全球约有5.28亿人患有骨关节炎,自1990年以来增加了113%。约73%的骨关节炎患者年龄超过55岁,其中60%是女性。膝关节的盛行率高达 3.65 亿,是最常受影响的关节,其次是髋关节和手部。
全球软骨修復市场按模式、应用部位、应用程式和最终用户进行细分。根据模式,市场分为基于细胞的和基于非细胞的。根据应用部位,市场可细分为踝关节、足部、膝关节和髋关节。根据应用,市场分为透明软骨和纤维软骨。此外,根据最终用户,市场分为医院和门诊手术中心。在这些治疗方式中,由于人们越来越倾向于将自体软骨细胞移植作为受损关节软骨(包括软骨和骨软骨病变)的手术治疗方法,因此基于细胞的细分市场预计将占据相当大的市场份额。
在应用领域中,膝关节细分市场预计将在全球软骨修復市场中占据相当大的份额。膝盖手术有多种因素造成,包括人口老化、研发活动投资、对微创手术的日益偏好、道路事故和运动相关伤害的增加。根据关节镜、运动医学和復健中心的数据,在这项研究中,21% 的球员发生了结构性膝关节损伤,每 1,000 场比赛中总体受伤率为 5.42 例。依年龄分层,结构性膝关节损伤发生率在20岁以下的球员中最高(3.23/1000 GE),其次是30岁以下(3.11/1000 GE)、25至29岁(2.97/1000 GE)和20岁以下。至 24 年 (2.26/100 GE)。以每场比赛分钟数计算,膝伤发生率最高的是上场时间超过30 分钟的球员(3.86/1000 GE),其次是20.0 至29.9 分钟(3.03/1000 GE)和10.0 至19.9 分钟(1.82/1000 GE)。
全球软骨修復市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于治疗率上升、药品价格上涨,预计亚太地区在预测年内将出现成长价格、先进的医疗技术、不断增长的可支配收入以及新兴经济体不断改善的医疗基础设施正在推动亚太地区的软骨修復市场。
在所有地区中,北美地区预计在预测期内将以相当大的CAGR成长。由于骨关节炎发病率上升、政府的积极倡议和高度发达的医疗基础设施等因素,北美市场正在不断增长。根据美国疾病管制与预防中心的数据,2019 年至 2021 年期间,约五分之一的美国成年人(21.2%)或约 5,320 万人患有医生诊断的关节炎。与男性 (16.3%) 相比,女性 (20.9%) 更容易患关节炎。因此,骨关节炎发生率的增加预计将推动对软骨修復和再生产品的需求。
服务软骨修復市场的主要公司包括 Zimmer Biomet Holdings, Inc.、Conmed Corp.、Stryker Corp.、Osiris Therapeutics, Inc.、Smith & Nephew Plc、Arthrex, Inc、RTI Surgical, Inc. 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2023 年 8 月,Marrow Access Technologies 与 Spartan Medical 签署了分销协议。该分销协议为退伍军人事务部(VA) 和国防部(DoD) 的患者提供了使用SmartShot (R) 骨髓访问设备的机会,这是一种利用人体自身干细胞和癒合能力来治疗骨科软组织的新解决方案肩膀、臀部、膝盖、脚踝和脚部受伤。
Global Cartilage Repair Market Size, Share & Trends Analysis Report by Types of Colorectal Cancer (Cell Based and Non-Cell Based), by Application Site (Ankle, Foot, Knee, and Hip), by Application (Hyaline Cartilage and Fibrocartilage), and by End-User (Hospitals and Ambulatory Surgical Centers), Forecast Period (2023-2030)
The global cartilage repair market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). The market growth is driven by the increasing incidence of bone and joint disorders, such as osteoarthritis, as well as advancements in cartilage regeneration technology. The increasing prevalence of osteoarthritis is attributed to factors such as the expanding geriatric population and the rising impact of obesity and other related factors. According to the WHO, in 2019, about 528 million people around the globe were living with osteoarthritis, an increase of 113% since 1990. About 73% of people living with osteoarthritis are older than 55 years, and 60% are female. With a prevalence of 365 million, the knee is the most frequently affected joint, followed by the hip and the hand.
The global cartilage repair market is segmented on the modality, application site, application, and end-user. Based on the modality, the market is sub-segmented into cell based and non-cell based. Based on the application site, the market is sub-segmented into ankle, foot, knee, and hip. Based on the application, the market is sub-segmented into hyaline cartilage and fibrocartilage. Further, based on end user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the modality, the cell based sub-segment is anticipated to hold a considerable share of the market, owing to the growing preference for autologous chondrocyte transplants as a surgical treatment for damaged articular cartilage, including chondral and osteochondral lesions.
Among the application site, the Knee sub-segment is expected to hold a considerable share of the global cartilage repair market. Various factors are attributed to the knee surgery including the increasing ageing population, investments in research and development activities, the growing preference for minimally invasive procedures, rising road accidents and sports-related injuries. According to the Arthroscopy, Sports Medicine, and Rehabilitation, structural knee injuries occurred in 21% of players in this study with an overall rate of 5.42 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.23/1000 GE) followed by less than 30 years old (3.11/1000 GE), 25 to 29 years (2.97/1000 GE), and 20 to 24 years (2.26/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.86/1000 GE), followed by 20.0 to 29.9 minutes (3.03/1000 GE), and 10.0 to 19.9 minutes (1.82/1000 GE).
The global cartilage repair market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to grow over the forecast year, owing to the rising treatment rates, inflated medicine prices, advanced medical technologies, the rising disposable income coupled with improving healthcare infrastructure in emerging economies are driving the cartilage repair market in the Asia Pacific.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to factors including the rising incidence of osteoarthritis, favorable government initiatives and highly developed healthcare infrastructure. According to the Centers for Disease Control and Prevention, during 2019-2021, about 1 in 5 US adults (21.2%) or about 53.2 million people had doctor-diagnosed arthritis. Arthritis was more common among women (20.9%) compared to men (16.3%). Thus, the increasing incidence of osteoarthritis is expected to drive the demand for cartilage repair and regeneration products.
The major companies serving the cartilage repair market include Zimmer Biomet Holdings, Inc., Conmed Corp., Stryker Corp., Osiris Therapeutics, Inc., Smith & Nephew Plc, Arthrex, Inc, RTI Surgical, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2023, Marrow Access Technologies signed a distribution agreement with Spartan Medical. The distribution agreement offered patients in the Department of Veterans Affairs (VA) and Department of Defense (DoD) access to the SmartShot® Marrow Access Device, a new solution for using the body's own stem cells and healing capabilities to treat orthopedic soft tissue injuries of the shoulder, hip, knee, ankle, and foot.